MedTrace Logo

Local Delivery of Silk Fibroin and Chlorhexidine

NCT06050863 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-09-22

No results posted yet for this study

Summary

The current study is a prospective randomised split mouth study to evaluate the effect of Silk fibroin as drug delivery system while simultaneously assessing the efficacy of silk fibroin in comparison to chlorhexidine.

Conditions

  • Periodontal Pocket

Interventions

BIOLOGICAL

silk fibroin

silk fibroin extracted from bombyx mori silk worm is processed in laboratory to form silk fibroin films

DRUG

Chlorhexidin

chlorhexidine is used

BIOLOGICAL

combination of silk fibroin and chlorhexidine

combination of silk fibroin and chlorhexidine is used

Sponsors & Collaborators

  • Krishnadevaraya College of Dental Sciences & Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-06-30
Completion
2024-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06050863 on ClinicalTrials.gov